Automated Media Preparation Instrument for Dissolution Testing
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) is conducting a market survey (Sources Sought) to identify vendors capable of providing an Automated Media Preparation Instrument for Dissolution Testing for its Irvine Medical Products Laboratory in Irvine, CA. This notice aims to determine market capabilities and potential small business participation for a future procurement. Responses are due May 10, 2026.
Scope of Work
The FDA requires a newly manufactured automated instrument to efficiently and accurately de-aerate, heat, and dispense dissolution testing media. Key capabilities include:
- Dispensing volumes between 250ml and 1000ml with ±5mL accuracy.
- In-line heating up to 45°C with ±2°C accuracy.
- Degassing media up to 3.0ppm and compatibility with up to 2% surfactants.
- Onboard controller with user interface, programmed methods, and dispensing reports.
- Portable design with a cart and a nozzle for in-place vessel filling.
- Standard US 115V electrical compatibility. The requirement includes supply, delivery, installation, operator training for two users, and a minimum 12-month warranty covering parts, labor, and technical support. Installation must be performed by a certified field service engineer.
Contract & Timeline
- Type: Sources Sought / Market Research (Anticipated Firm-Fixed-Price for future procurement)
- Set-Aside: Total Small Business Set-Aside (FAR 19.5) is being considered; responses will help determine appropriateness.
- Response Due: May 10, 2026
- Published: May 13, 2026
- Place of Performance: FDA's Irvine Medical Products Laboratory, Irvine, CA.
- Anticipated Schedule: Delivery within 60 days after award; installation within 30 days after delivery.
Requested Information
Vendors should provide company details (name, address, CAGE, UEI), recommended NAICS (334516, 1,000 employees size standard), socio-economic status, GSA Schedule information, domestic manufacturing status, and technical specifications of proposed solutions.
Submission Instructions
Responses must be emailed to Reagan.Davis@fda.hhs.gov by the due date. The subject line should be "Sources Sought Notice Number: SSN_ OC-2026-133856 – Automated Media Preparation Instrument for Dissolution Testing". This is not a solicitation, and no contract will be awarded from this notice.